Leveraging Humanized & Syngeneic Models for Autoimmune Therapies to Advance Drug Efficacy
Time: 1:30 pm
day: Conference Day One
Details:
- Utilizing humanized models with research-grade drug equivalents to enhance clinical relevance, accelerating IND approval
- Comparing syngeneic vs. humanized Lupus models to optimize efficacy studies, streamlining autoimmune drug development
- Integrating hypoimmune “cloaking” technology to prevent cell rejection expanding potential for Inflammatory Bowel Disease/ Type 1 Diabetes
